<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01799109</url>
  </required_header>
  <id_info>
    <org_study_id>MS-2012CQ</org_study_id>
    <nct_id>NCT01799109</nct_id>
  </id_info>
  <brief_title>Lung Function of Asthmatic Children by Nebulized MgSO4</brief_title>
  <official_title>Lung Function Changes of Mild to Moderate Asthmatic Children Treated by Nebulized MgSO4</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chongqing Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chongqing Medical University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Asthma is a common chronic respiratory illness which results in frequent wheezing,
      cough,reduced quality of life. Standard treatment for asthma attack includes oxygen therapy,
      β2-agonists (e.g. albuterol) and inhaled anticholinergics and corticosteroids. Although
      inhaled short-acting β2-agonists (SAB) is the initial choice to control acute asthma
      exacerbation, there are still some asthmatic children unresponsive to this management. The
      Global Initiative in National Asthma (GINA) does not recommend intravenous magnesium sulfate
      (MgSO4) for routine use in asthma exacerbation especially in young children. But intravenous
      MgSO4 can reduce hospital admission rates in certain patients due to several effects e.g
      relaxation of smooth muscle,blocking acetylcholine. In addition,adding MgSO4 to nebulized SAB
      provides greater benefit in severe asthma exacerbation.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2011</start_date>
  <completion_date type="Actual">March 2012</completion_date>
  <primary_completion_date type="Actual">January 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>changes of lung function</measure>
    <time_frame>10minutes and 20minutes post-dose</time_frame>
    <description>to observe changes of Forced expiratory volume in one second and peak expiratory flow in controlled asthmatic children after respectively nebulized MgSO4、albuterol and combination of MgSO4 and albuterol in lung function test.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Nebulized magnesium sulfate alone effectively improve lung function</measure>
    <time_frame>10minutes and 20minutes post-dose</time_frame>
    <description>After Ach challenge,FEV1 and PEF decreased in all three groups.But only in albuterol and magnesium group,they presented statistically significant while not in combination therapy group.After each intervention, FEV1 and PEF increased.But there was only statistically significant in FEV1 of magnesium and PEF of albuterol at 10 minutes and these two treatment at 20 minutes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the number of participants with adverse events as a measure of safety and tolerability</measure>
    <time_frame>20minutes</time_frame>
    <description>to observe if anyone appear side effects such as nausea, vomiting, hypotension et al in patients who participating in our experiment. we did not found adverse reaction or other side effect in the study.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">90</enrollment>
  <condition>Asthma</condition>
  <arm_group>
    <arm_group_label>nebulization ms and albuterol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>magnesium sulfate 150mg &amp; albuterol 2.5mg nebulized with 5-6L/min of oxygen and consisted about 5 min,which used only once</description>
  </arm_group>
  <arm_group>
    <arm_group_label>nebulized albuterol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>albuterol 2.5mg nebulized with 5-6L/min of oxygen and consisted about 5 min,which used only once</description>
  </arm_group>
  <arm_group>
    <arm_group_label>nebulized ms</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>magnesium sulfate 150mg nebulized with 5-6L/min of oxygen and consisted about 5 min,which used only once</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Magnesium Sulfate &amp; albuterol</intervention_name>
    <arm_group_label>nebulization ms and albuterol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>albuterol</intervention_name>
    <arm_group_label>nebulized albuterol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>magnesium</intervention_name>
    <arm_group_label>nebulized ms</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  asthmatic children with controlled clinical manifestation

        Exclusion Criteria:

          -  fever

          -  history of chronic disease like bronchopulmonary dysplasia or cystic fibrosis

          -  allergic to acetylcholine, albuterol or magnesium

          -  use any bronchodilator agents before the Clinic day
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>4 Years</minimum_age>
    <maximum_age>10 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jihong Dai, professor</last_name>
    <role>Study Director</role>
    <affiliation>Chongqing Medical University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Center of Respiratory Disorders,Children's Hospital,Chongqing medical university</name>
      <address>
        <city>Chongqing</city>
        <state>Chongqing</state>
        <zip>400014</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>May 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 23, 2012</study_first_submitted>
  <study_first_submitted_qc>February 23, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 26, 2013</study_first_posted>
  <last_update_submitted>May 17, 2013</last_update_submitted>
  <last_update_submitted_qc>May 17, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 21, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chongqing Medical University</investigator_affiliation>
    <investigator_full_name>Dai Jihong</investigator_full_name>
    <investigator_title>professor</investigator_title>
  </responsible_party>
  <keyword>magnesium sulfate</keyword>
  <keyword>nebulization</keyword>
  <keyword>lung function</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Albuterol</mesh_term>
    <mesh_term>Magnesium Sulfate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

